# Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

> **NCT06562777** · — · RECRUITING · sponsor: **OHSU Knight Cancer Institute** · enrollment: 100 (estimated)

## Conditions studied

- Hematopoietic and Lymphatic System Neoplasm
- Malignant Solid Neoplasm

## Interventions

- **OTHER:** Non-Interventional Study

## Key facts

- **NCT ID:** NCT06562777
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-15
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06562777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06562777, "Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06562777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*